Leishmania major is a protozoan parasite that is transmitted to the mammalian host by its sand fly vector when the fly probes in the host's skin for a blood meal and injects the parasite within its saliva. In mice experimentally infected with L. major, outgrowth of CD4 type 1 (Th1) cells leads to resolution of the infection, but outgrowth of type 2 (Th2) cells exacerbates disease. To design an effective vaccine against the parasite (and other pathogens that induce polarized Th1 and Th2 responses), we must determine the mechanism underlying this phenomenon so that we can design the vaccine to elicit the appropriate (i.e., protective) Th cell. Recent work indicates that Th bias is influenced by a number of signals delivered by antigen-presenting cells, including cytokines and co-stimulatory molecules. Moreover, recent work also suggests that sand fly saliva influences the immune response to L. major and Th polarization. Determining the mechanisms that lead to polarized Th responses should expand our knowledge regarding immunity to L. major, and should add to our understanding of immunoregulation in general. ß
Leishmania and leishmaniasis
Members of the genus Leishmania are sand £y-transmitted protozoan parasites that cause leishmaniasis in their vertebrate hosts. The parasite is transmitted to the host when the sand £y vector probes in the skin for a blood meal and injects the promastigote form of the parasite within its saliva. Importantly, the saliva dramatically enhances the infectivity of the parasite for the host. When a large number of parasites (10 4^1 0 6 ) are injected into experimental mice, saliva markedly enhances infection compared to the infection in saliva-free control animals. When the number of parasites injected by the sand £y (V100) is injected, the parasite does not survive unless it is co-injected with sand £y saliva [1] . Thus, saliva may be critical for natural transmission of Leishmania by sand £ies. Sand £ies that transmit the parasite in the Old World are of the genus Phlebotomus and those that transmit Leishmania in the New World are of the genus Lutzomyia.
Leishmaniasis currently a¥icts some 12 million individuals, with 350 million at risk [2] . In addition, HIV has compounded the acquisition/re-activation of leishmaniasis, and recent epidemics of leishmaniasis in such places as Sudan have been particularly devastating [2] . Moreover, there are still no e¡ective control measures for the disease.
Within the mammalian host Leishmania resides as an amastigote in phagocytic cells such as macrophages, dendritic cells and neutrophils (reviewed in [3^5], space limitations do not permit a thorough survey of the literature). The clinical manifestations of leishmaniasis depend not only upon the species of parasite infecting the host, but the general health and genetic constitution of the infected individual. In general, parasites that cause cutaneous leishmaniasis (Leishmania major, Leishmania tropica and Leishmania aethiopica in the Old World and Leishmania braziliensis and Leishmania mexicana in the New World) induce a lesion at the site of the insect bite, which takes months to heal.
2. The Th1/Th2 paradigm in experimental mice infected with L. major
Infection of experimental mice with L. major promastigotes is perhaps the best-studied model of a chronic infectious disease that involves activation of CD4 type 1 (Th1) and type 2 (Th2) cells. Th1 and Th2 cells can be distinguished by the cytokines they secrete: Th1 cells secrete activators of cell-mediated immunity such as interferon (IFN)-Q, while Th2 cells secrete cytokines such as interleukin (IL)-4 which promote antibody responses. Most strains of mice (C57BL/6, C3H, CBA) develop a self-limiting cutaneous disease when infected with L. major. In these mice, resolution of infection is mediated by Th1 cells that produce IFN-Q. IFN-Q induces production of nitric oxide (NO) in phagocytic cells that harbor L. major (principally macrophages) which leads to destruction of the parasite. Therefore, infection with L. major in these strains of mice resembles self-limiting cutaneous leishmaniasis in humans.
In contrast, other strains of mice (notably, BALB/c) develop a Th2 response following infection with L. major. Within minutes to hours after infection with L. major, VL4VK8 CD4 T cells in BALB/c mice produce IL-4 mRNA in response to a single parasite antigen, LACK (Leishmania homolog of receptors for activated C kinase). IL-4 down-regulates expression of the L2 subunit of IL-12 receptors on potentially protective Th1 T cells. As a result the cells become unresponsive to IL-12 and production of IFN-Q and NO is inhibited. Thus, L. major parasites within macrophages are not killed. Rather, IL-4 promotes the outgrowth of Th2 T cells, which stimulate the production of parasite-speci¢c antibodies [3^5] .
It should be noted however that the explanation for the susceptibility of BALB/c mice to infection with L. major may be more complicated than that outlined above. For example, in certain cases IL-4-de¢cient BALB/c mice (e.g., see [6] ) are still susceptible to infection with the parasite. This observation may in part be explained by the fact that IL-4-de¢cient BALB/c mice are more or less susceptible to infection with L. major depending upon the substrain of parasite used to infect the mice, since some strains of L. major induce a full-blown infection in IL-4-de¢cient BALB/c mice while others do not [7] . Thus, the susceptibility of BALB/c mice to infection with L. major may be dependent upon the ability of the parasite to induce not only the production of IL-4, but also other cytokines such as IL-13 [8] and IL-10 [9, 10] , which also promote susceptibility to infection with the parasite. Finally, it has been reported that BALB/c mice that bear a transgenic L2 subunit of the IL-12 receptor are still susceptible to infection with L. major, which calls into question the notion that down-regulation of the L2 subunit of the IL-12 receptor is a key prerequisite for the susceptibility of BALB/c mice to infection with the parasite [11] .
Nevertheless, in general, Th1 cell-mediated immune responses control intracellular infections such as leishmaniasis and tuberculosis, while Th2 antibody-mediated immune responses are best suited for extracellular pathogens such as intestinal worms.
The in£uence of co-stimulatory molecules on Th bias
Activation of T cells requires two signals: cognate recognition of the antigen for which the T cell is speci¢c (which can be accomplished by interactions between the major histocompatibility complex and the T cell receptor) and a co-stimulatory signal(s), normally provided by antigen-presenting cells. Since L. major resides in the phagolysosome of antigen-presenting cells and the phagolysosome also contains major histocompatibility complex class II molecules, the predominant T cell response to the parasite is a CD4 ; however, other T lineage cells are involved in this response such as CD8, NK and QN T cells.
Dendritic cells and macrophages are antigen-presenting cells that play a central role in leishmaniasis. Dendritic cells harbor few parasites but are highly e⁄cient at stimulating naive T cells. In contrast, macrophages are avid scavengers of Leishmania but are permissive to infection unless they are stimulated by cytokines (e.g., IFN-Q; [12] ). It has been shown that skin dendritic cells (known as Langerhans cells) can migrate from a site of infection with L. major to the draining lymph node where they can stimulate L. major-speci¢c T cells [12] . During this migration and their subsequent interaction with T cells, dendritic cells mature into potent antigen-presenting cells. This is in part mediated through interactions between CD40 (expressed on dendritic cells) and CD40 ligand (CD40L, expressed on T cells) and this leads to changes in expression of major histocompatibility complex class II and B7s (CD80 and 86 [13] ). B7s are expressed on antigenpresenting cells and their ligands (CD28 and CTLA-4) are expressed on T cells. Ligation of CD28 by B7s activates T cells, however ligation of CTLA-4 can deliver a negative signal to the T cell, thus limiting T cell expansion. A summary of the role of molecules such as CD40 and B7 as well as cytokines in inducing L. major-speci¢c Th1 and Th2 cells is presented in Fig. 1 .
It has been shown that CD40 and CD40L are required for resistance to L. major infection since CD40 and CD40L-de¢cient mice are highly susceptible to infection with L. major [14, 15] . In contrast, the role of B7s (CD80 and 86) is less clear. Although B7^CD28 interactions appear to have little e¡ect on the outcome of L. major infection in mice, treating with CTLA-4Ig reversed the disease phenotype in susceptible but not in resistant mice, suggesting that interactions between B7s and CTLA-4 are important in the immune response to L. major. Sub-sequent work (with one exception, [16] ) con¢rmed that both CD80 and 86 are involved in activation of T cells in mice infected with L. major (discussed in [17] ).
Indeed our own recent work supports an important role for dendritic cells/Langerhans cells and B7 expression in immunity to L. major [18] . When we infected mouse epidermal cells enriched for Langerhans cells with L. major (which we feel is the best model to study since L. major would encounter all of these cell types when it is injected into the skin of mice), we found that CD40 expression was unchanged, but B7-1 expression was reduced on BALB/c (susceptible) Langerhans cells while B7-2 expression was reduced on C3H (resistant) epidermal cells.
Interestingly, while resistant C3H T cells did not produce IL-4 unless stimulated by BALB Langerhans cells/ epidermal cells, BALB T cells made IL-4 whether stimulated by syngeneic or congenic Langerhans cells/epidermal cells (Fig. 2) . However, in all cases blockade of B7-2 inhibited IL-4 production. Taken as a whole, these data suggest that while both B7-1 and B7-2 on Langerhans cells are involved in co-stimulating IFN-Q production, B7-2 alone co-stimulates IL-4 production. This result agrees with our previous results, which showed that treating L. major-infected mice with anti-B7-2 was protective for the mice and decreased IL-4 production [19] . The results discussed above also demonstrate that dynamic interactions can occur between skin antigen-presenting cells and responding T cells. Indeed, when resistant C3H T cells are stimulated with C3H skin antigen-presenting cells, they, as expected, do not produce IL-4, but the T cells do make IL-4 when they are stimulated with susceptible BALB.K skin antigen-presenting cells. Therefore, the antigen-presenting cell environment can reverse the phenotype of responding T cells [18] .
Finally, recent experiments have shown that the co-stimulatory molecule OX40 (Fig. 1) is critical for Th2 development in susceptible BALB/c mice infected with L. major [20] , and B7-DC (which is expressed exclusively on dendritic cells) is a potent signal for IFN-Q production [21] .
The in£uence of cytokines on Th bias
Perhaps the most important cytokine involved in resistance to L. major in mice is IL-12. IL-12 induces IFN-Q production by T cells and NK cells and IFN-Q can induce the production of NO and parasite clearance by macrophages. Dendritic cells are perhaps the most important source of IL-12 (discussed in [22] ). L. major has been shown to induce IL-12 production by dendritic cells and However, in addition to IL-12 and IL-4, several other cytokines have marked e¡ects on infection with L. major in mice (Fig. 1) . For instance, tumor necrosis factor (TNF)-K is critical for resolution of a L. major infection since infection with the parasite in TNF-K knockout mice is fatal [23] . Among the many ways in which TNF-K may play a role, the most obvious is its ability to enhance macrophage activation, NO production and thus parasite clearance. Similar to IL-12 and TNF-K, IFN-K/L is also produced by antigen-presenting cells. IFN-K/L (also known as type 1 IFN) can induce cell activation, including activation of macrophages to produce NO to kill L. major (discussed in [24] ). As a result, treating mice infected with L. major with a neutralizing anti-IFN-K/L was detrimental for the course of infection. Taken as a whole, these observations suggest that several cytokines produced by antigen-presenting cells (IL-12, TNF-K and IFN-K/L) can promote the development of a protective Th1/IFN-Q response to L. major infection There are also cytokines (which again can be produced by antigen-presenting cells) that promote the development of a Th2 response to infection with L. major in mice. Transforming growth factor-L can inhibit the production of IFN-Q and can 'deactivate' macrophages, making them more permissive to infection with Leishmania [25] . Likewise, IL-10 can also inhibit the production of IFN-Q and thus has been referred to as a cytokine that favors Th2 development. However, injecting mice with IL-12 triggers both IFN-Q and IL-10 gene expression [26] . In addition, when infected with L. major, resistant mice produce more IL-10 than susceptible mice [27] . Taken together these observations suggest that IL-10 may also participate in a feedback loop to prevent overproduction of IFN-Q and possible tissue damage. Finally, IL-6 has been proposed to favor the development of Th2 responses [28] . However, when IL-6-de¢cient mice on a susceptible BALB/c background were infected with L. major, the course of infection was not di¡erent from control animals. The absence of IL-6 led to down-regulation of both Th1-(IL-12) and Th2-associated (IL-4, IL-10 and IL-13) cytokines. Thus, in mice infected with L. major, IL-6 may promote the development of both Th1 and Th2 responses [29] .
The in£uence of vector sand £y saliva on Th bias
Saliva is co-injected with Leishmania into the skin of the vertebrate host when the sand £y takes a blood meal. It is now well established that the lysates of the salivary gland of the sand £y vector for Leishmania (both Old and New World species) exacerbate infection with the parasite in the mammalian host [1, 30, 31] . For a recent review of the im- Fig. 3 . Vaccination against L. longipalpis MAX protects mice from a subsequent challenge with L. major admixed with whole L. longipalpis salivary-gland lysates. Groups of C3H mice were vaccinated with synthetic MAX emulsi¢ed in Freund's adjuvant or were sham-vaccinated (received adjuvant alone). Both groups were then challenged in the footpad with L. major parasites mixed with salivary-gland lysate of L. longipalpis. The lesions were monitored by comparing the thickness of the infected footpad with the contralateral control footpad. See reference [35] for further experimental details.
munomodulatory properties of sand £y saliva that are involved in this phenomenon, the reader is referred to Gillespie et al. [32] or Kamhawi [33] . The immunomodulatory properties of whole saliva (from either Old or New World sand £ies) or of maxadilan (or MAX, a potent vasodilator/immunomodulator present in the saliva of New World sand £ies) would be expected to exacerbate leishmaniasis (summarized in Table 1) , and thus could be the explanation for the e¡ect of saliva/MAX on infection with L. major. For example, saliva increases IL-4 production, and IL-4 is one of the most important factors that leads to disease progression in L. major-infected mice (discussed in Section 2.2 above). In addition, saliva/MAX up-regulates the production of prostaglandin E 2 , IL-10 and IL-6, which can inhibit macrophage activation. Indeed the activation of saliva/MAX-treated macrophages is inhibited since the cells are less capable of producing TNF-K, NO and H 2 O 2 ( Table 1) , all of which are markers for macrophage activation.
One of the most exciting aspects in Table 1 is the recent discovery that salivary-gland proteins can be used to vaccinate against infection with L. major [34, 35] . Using Old World Phlebotomus papatasi sand £ies, Valenzuela et al. [34] showed that a protein in the saliva of the £y (SP-15) was highly immunogenic for mice. They therefore vaccinated mice against the protein and then challenged the mice with L. major admixed with whole P. papatasi salivary-gland lysate. The result was marked protection against infection with the parasite. Using New World Lutzomyia longipalpis MAX, Morris et al. [35] also showed that MAX-vaccinated mice were markedly protected against challenge with L. major. An example of the results achieved with MAX vaccination is shown in Fig. 3 . Vaccinated animals had lesions considerably smaller than control (sham-vaccinated) mice and these lesions healed approximately 4 weeks in advance of the controls. Interestingly, in both the work of Valenzuela and Morris, an analysis of the mechanism of protection showed that cell-mediated responses in the vaccinated mice (delayed type hypersensitivity and IFN-Q) were at least partly responsible for the protection observed.
The advantage to this approach towards vaccination is that, theoretically, vaccinating against the salivary proteins of a given vector would protect the host from infection with any pathogen the vector transmits. Since there are numerous vector-borne diseases (malaria, ¢lariasis, trypanosomiasis, leishmaniasis and Lyme disease, to name but a few), this type of vaccine would be both novel and e⁄-cient. The e⁄cacy of this type of vaccine in humans, however, has yet to be explored.
Human leishmaniasis
The immune response of humans to infection with Leishmania is not as well characterized as the response of mice. However, we will attempt to summarize the commonalities of the human response to Leishmania with respect to the role of cytokines, co-stimulatory molecules and sand £y saliva. It should be noted that this summary will encompass the human response to several species of Leishmania, with an emphasis on those that cause cutaneous leishmaniasis.
The clinical outcome of infection with Leishmania in humans ranges from a relatively mild to a severe lifethreatening disease depending on several host and parasite factors. Among these are the species/isolate of Leishmania that is involved, however, it is clear that a single strain of Leishmania can give rise to more than one clinical form of the disease, which include cutaneous, mucocutaneous, and visceral. These di¡erences are also likely in£uenced by the patient's own immune response [36] .
Information on the nature of the cell in¢ltrate in humans with cutaneous leishmaniasis has been obtained principally through the analysis of lesion biopsies. This approach has limitations because it only allows for a single 'snapshot' of the infectious process. Nevertheless, the predominant cells found in the lesion are CD4 and CD8 T cells, with lower numbers of macrophages, granulocytes and a few B cells [37] .
Although there are exceptions, lymphocytes from patients with active leishmaniasis produce mainly IFN-Q and some IL-4 in response to stimulation with the parasite; cure of the infection is associated with the production of IFN-Q only, while IL-10 may prolong the course of disease [38^40] . A small portion of individuals infected with L. braziliensis develop mucosal lesions, which are associated with a strong cellular response and the expression of IFN-Q, TNF-K and IL-10 [41] .
In an e¡ort to gain more control over experimental conditions and the timing and dose of infective parasites, some investigators have studied the response of peripheral blood mononuclear cells (PBMC) from Leishmania-unexposed normal donors to infection with the parasite in vitro. A similar approach (using spleen or lymph node cells) in a murine system was shown to mimic closely the immune response that occurs to infection with L. major in an intact mouse [27] . Hviid et al. [42] showed that phenotypic changes (e.g., CD3 and CD25 expression) occurred in PBMC when the cells were exposed to Leishmania donovani in vitro, and Kurtzhals et al. [43] reported that PBMC produced IFN-Q in response to stimulation with L. donovani. More recently, we [44, 45] and Rogers and Titus, unpublished, showed that most donors developed a Th1 or Th0 (Th0 cells display a mixed Th1^Th2 phenotype) response to stimulation with L. major in vitro. Moreover, we found that expression of CD80 and CD40 was enhanced on macrophages exposed to L. major and responding lymphocytes, and that blocking CD80 and/or CD86 interfered with the production of IL-5 and IFN-Q by T cells and IL-12 by L. major-infected macrophages. Finally, we also showed (Rogers and Titus unpublished) that sand £y sa-liva and/or salivary MAX inhibits IFN-Q production by human PBMC infected with L. major while it stimulates the production of IL-6 by human macrophage/monocytes. This suggests that MAX a¡ects the human and mouse immune systems similarly and that therefore MAX may be useful in the development of anti-Leishmania vaccines for humans.
Taken as a whole, these results using normal human PBMC stimulated with Leishmania in vitro appear also to yield results that mimic infection in humans just as the murine in vitro system mimics infection in the mouse. Therefore, the human in vitro system may prove useful for dissecting the immune response of humans to Leishmania, especially during the ¢rst few hours and days of infection, which may prove to be critical to understanding the immune response of humans to the parasite.
Conclusions and future directions
It is clear that polarization of Th responses to either Th1 or Th2 can lead to life or death outcomes to infection with L. major in mice. However, this is the downstream e¡ect of the infection. What needs to be explored is the upstream events that lead to this polarization. Recent work has revealed that the antigen-presenting cell/co-stimulatory molecule/cytokine environment in which T cells are primed in£uences Th priming. Many of the cells that deliver these signals to T cells (e.g., antigen-presenting cells such as dendritic cells and macrophages) are members of the innate immune system. Therefore, further work is needed to analyze the interactions that occur between the innate and adaptive immune systems in animals infected with L. major. In addition, the e¡ects that sand £y salivary proteins have on these interactions should also be explored since these salivary proteins have such dramatic e¡ects on the immune response of the host and therefore might be useful as components of a subunit vaccine directed against Leishmania.
